Research Identifies New Mechanism Regulating Embryonic Development
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism’s DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer…Original post by Allergy News From Medical News Today
No commentsHealth Overhaul Policy Tidbits
NPR: For those who have forgotten what the Senate’s bill would actually do as the debate has turned to politics and procedure, “a short refresher” may come in handy…Original post by Six Until Me.
No commentsSenate Test Vote Today On Bill To Extend COBRA Subsidy, Doc Fix And State Medicaid Funding
The Senate is poised to consider a measure today that would include extending subsidies for COBRA benefits and unemployment insurance, prevent the Medicare payment cut for doctors and provide additional funding to state Medicaid programs…Original post by Six Until Me.
No commentsGenetic Variant Greatly Increases Lung Cancer Risk For Light Smokers
Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati (UC) has concluded…Original post by Allergy News From Medical News Today
No commentsGOP Candidate For Calif. Gov. Switches Positions On Abortion-Related Issues
California Insurance Commissioner Steve Poizner, who is seeking the Republican gubernatorial nomination, took liberal positions on abortion-rights issues when he unsuccessfully ran for state Assembly in 2004, the Los Angeles Times reports. Poizner’s past statements supporting abortion-right issues contradict the conservative stance he has taken in his current campaign…Original post by Six Until Me.
No commentsStupak Indicates Abortion Compromise Possible For Health Bill
Rep. Bart Stupak, D-Mich., who is leading a coalition of anti-abortion Democrats standing in the way of party leadership efforts to pass a health bill, signaled Monday that the impasse may be close to resolution…Original post by Six Until Me.
No commentsAdministration, Health Insurers Point Fingers At Each Other In Premium Hike Dust-Up
The Obama administration and insurance industry executives are continuing their battle over rate increases. Politico: “Insurance industry executives sat down with administration officials in the White House last week to justify their rising premium costs, attributing them to increasing medical costs. But it’s an answer President Barack Obama apparently wasn’t buying…Original post by Six Until Me.
No commentsObama Attacks Insurers, Rallies Public To Press Congress To Approve Health Reform
“The White House is mounting a stinging, sustained broadside against health insurance rate increases,” The Washington Post reports, adding that President Obama “and his health secretary staged a two-pronged attack Monday in a stern letter to health insurance chief executives and a speech in which the president castigated insurance companies 22 times…Original post by Six Until Me.
No commentsCornyn And Boehner Sharpen Criticism Of Obama Health Proposal
News outlets report on health care remarks from GOP leaders. “National Republican Senatorial Committee Chairman John Cornyn said Monday that if some type of health care legislation is able to limp its way out of Congress, GOP candidates across the country are poised to make it the premiere issue of the fall campaign,” Politico reports…Original post by Six Until Me.
No commentsCellectar Completes Enrollment In Phase I Clinical Trial Of Lead Drug Candidate (131)I-CLR1404 For The Treatment Of Solid Malignancies
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year…Original post by Allergy News From Medical News Today
No comments